Business
Anthropic nears $6 billion deal for Israeli AI startup Decart, creating new billionaires
Decart's shareholders believe they can produce a higher return from shares of a company like Anthropic, which is planning to launch the largest IPO in history, at a company valuation of $2 trillion.
Australian lawyer makes aliyah just before October 7, quits job to launch babywear brand
‘My form of Zionism’: Jerusalem nonprofit helps new olim build businesses in Israel
Anthropic in talks to acquire Israeli AI startup Decart for $6 billion
'It started on October 7': How war reshaped Israel's defense-tech boom
From battlefield needs to global strategy, defense tech is accelerating, with Israel emerging at the center of a rapidly evolving sector
Inside Inspiraction, the Jerusalem incubator helping young Israelis turn ideas into start-ups
Jerusalem incubator connects young entrepreneurs with investors to refine early concepts.
Real estate giant invests $200 million into Miami’s high-tech hub: What’s Flow Wynwood?
The Flow Wynwood project will raise the current $200 million valuation of the complex over the $300 million line, Flow said, citing market sources' estimates.
Report: Smartphone giants OnePlus and Realme are merging
After months of rumors about scaling down operations, reports in China reveal that smartphone brands OnePlus and Realme will join forces under a shared product center.
Almost half of operational decisions will be done by AI in 2030, IBM reveals - poll
CEOs expect AI to handle 48% of operational decisions autonomously, primarily in areas with clear, established rules and procedures.
The systems architect: Omer Menashe, Israeli-born innovator reshaping American venture building
Not just to New York: Arkia introduces business class on flights to Europe
For the first time on its European routes, Arkia launches a business class on its Paris route with spacious seating, VIP service, lounge access, extended baggage allowance, and prices from $849.
A strategic miss: R&D is Israel's brain - so why does it develop, manufacture abroad? - opinion
Israel excels in algorithms and exits, but we have forgotten a basic principle: The higher you move up the value chain, the greater the profit.
Mega deal: Teva acquires Emalex for approximately $900 million
The Israeli pharmaceutical giant is accelerating its growth strategy and adding to its portfolio a groundbreaking treatment for Tourette syndrome in children.
Your Taxes: Israel’s lower mid-market is tempting international M&A buyers
Bargaining factors: Several factors are contributing to what can best be described as a ripening of the market.
